Metformin vs. Amaryl

See how Metformin and Amaryl compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Metformin is a biguanide that lowers blood sugar mainly by reducing liver glucose production and is the standard first choice for type 2 diabetes.

  • Amaryl (glimepiride) is a sulfonylurea that lowers blood sugar by prompting the pancreas to release more insulin, which raises hypoglycemia risk.

  • Doctors often start with metformin alone and add Amaryl later if blood sugar control needs more help.

Metformin vs. Amaryl Drug Summary

Metformin

Metformin is a biguanide used to control blood sugar in adults and children 10 and older with type 2 diabetes. It works by reducing how much glucose the liver releases and by improving the body's response to insulin. It comes as an immediate-release tablet, extended-release tablet, or oral solution, usually taken with meals.

Amaryl

Amaryl (glimepiride) is a sulfonylurea used along with diet and exercise to control blood sugar in adults with type 2 diabetes. It works by signaling the pancreas to release more insulin after meals. It is taken as a once-daily oral tablet, usually with breakfast or the first main meal.

Metformin vs. Amaryl Side Effects

Metformin

Most common
Diarrhea (>5%)
Nausea/vomiting (>5%)
Flatulence (>5%)
Asthenia (>5%)

Amaryl

Most common
Hypoglycemia (up to 19.7%)
Accidental injury (up to 16%)
Dizziness (up to 5%)
Asthenia (up to 5%)

Metformin vs. Amaryl Dosage

Metformin

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 500 mg twice daily Week 1
Maximum dose 500 mg once daily Week 1
Dose changes 2 increases As tolerated

Amaryl

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 1 mg or 2 mg once daily At the start
Maximum dose 1 mg or 2 mg once daily Same as starting
Dose changes None Fixed dose

Metformin vs. Amaryl Indications

Metformin

Metformin is FDA-approved to improve blood sugar control in adults and in children 10 and older with type 2 diabetes. It is also commonly prescribed off-label for polycystic ovary syndrome and for prediabetes or weight management, though these are not FDA-approved uses.

  • Type 2 diabetes in adults

  • Type 2 diabetes in children 10 and older

  • Off-label: polycystic ovary syndrome (PCOS)

  • Off-label: prediabetes or weight management

Amaryl

Amaryl is FDA-approved as an add-on to diet and exercise to improve blood sugar control in adults with type 2 diabetes. It is also approved for combination use with insulin in patients whose blood sugar is not adequately controlled by either drug alone.

  • Type 2 diabetes in adults, with diet and exercise

  • Combination therapy with insulin when needed

  • Not approved for type 1 diabetes

  • Not approved for diabetic ketoacidosis

Metformin vs. Amaryl Pros and Cons

Metformin

Metformin has decades of use as the standard first-line drug for type 2 diabetes and carries a low risk of causing low blood sugar on its own. Its main drawbacks are gastrointestinal side effects and a boxed warning about a rare but serious buildup of lactic acid.

Pros

  • First-line therapy recommended by major diabetes guidelines

  • Low risk of hypoglycemia when used alone

  • Decades of long-term safety data

  • Also used off-label for PCOS and prediabetes

Cons

  • Gastrointestinal side effects are common, especially early on

  • Contraindicated in patients with severe kidney impairment

  • Carries a boxed warning for lactic acidosis

  • Must be paused before certain contrast dye procedures

Amaryl

Amaryl offers simple once-daily dosing and is the only sulfonylurea specifically approved for combination use with insulin. Its main trade-offs are a meaningful risk of low blood sugar and warnings about cardiovascular safety compared with diet alone.

Pros

  • Simple once-daily dosing schedule

  • Approved for combination use with insulin

  • Longer duration of action than older sulfonylureas

  • Effective add-on when metformin alone is not enough

Cons

  • Notable risk of hypoglycemia, including severe episodes

  • Warning about possible increased cardiovascular mortality risk

  • Postmarketing reports of serious hypersensitivity reactions

  • Not considered first-line therapy in current guidelines

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.